- Category :
Pharmaceuticals and Biochemicals
- CAS NO : 231277-92-2
- EC NO :
- Molecular Formula : C29H26ClFN4O4S
- Main Specifications : 99%
- Synonyms : 4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-;N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine;N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine;Lapatinib base;
Package: As customer request
Uses : antineoplastic, tyrosine kinase inhibitor
Molecular Structure:
Product description:
Product Name: Lapatinib
Synonyms: lapatinib;n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-
CAS: 231277-92-2
MF: C29H26ClFN4O4S
MW: 581.0575432
EINECS: 1806241-263-5
Uses:
1. Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.
2.antineoplastic, tyrosine kinase inhibitor
3.An antineoplastic agent used in breast cancer research